MedAdvisor (MDR) Stock Price, News & Analysis

Company Overview

MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 719,064 shs
• Average Volume: N/A
• Market Capitalization: A$91.07 million
• P/E Ratio: 114.55
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: ASX:MDR
• CIK: N/A
• Web: www.medadvisor.com.au
• Phone: 61 3 9095 3036
• Fax: N/A
• Employees: 31,900
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 114.55
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$9.03 million
• Net Margins: 0.65%
• Pretax Margin: N/A
• Return on Equity: 1.48%
• Return on Assets: 1.79%

Debt

• Debt-to-Equity Ratio: 24.44
• Current Ratio: 0.71
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: A$122.11 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 7.95
• Book Value: A$0.09 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 551,310,000
• Free Float: N/A
• Market Cap: A$91.07 million
• Optionable: Not Optionable
• Beta: 0.67